- Home
- ASRT vs DTF Comparison
ASRT vs DTF Comparison
Compare ASRT & DTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRT
- DTF
- Stock Information
- Founded
- ASRT 1995
- DTF 1991
- Country
- ASRT United States
- DTF United States
- Employees
- ASRT N/A
- DTF N/A
- Industry
- ASRT Biotechnology: Pharmaceutical Preparations
- DTF Investment Managers
- Sector
- ASRT Health Care
- DTF Finance
- Exchange
- ASRT Nasdaq
- DTF Nasdaq
- Market Cap
- ASRT 85.1M
- DTF 79.4M
- IPO Year
- ASRT 1997
- DTF N/A
- Fundamental
- Price
- ASRT $0.83
- DTF $11.32
- Analyst Decision
- ASRT Strong Buy
- DTF
- Analyst Count
- ASRT 4
- DTF 0
- Target Price
- ASRT $3.19
- DTF N/A
- AVG Volume (30 Days)
- ASRT 419.9K
- DTF 21.1K
- Earning Date
- ASRT 03-10-2025
- DTF 01-01-0001
- Dividend Yield
- ASRT N/A
- DTF 3.64%
- EPS Growth
- ASRT N/A
- DTF N/A
- EPS
- ASRT N/A
- DTF 0.44
- Revenue
- ASRT $125,763,000.00
- DTF N/A
- Revenue This Year
- ASRT N/A
- DTF N/A
- Revenue Next Year
- ASRT $1.84
- DTF N/A
- P/E Ratio
- ASRT N/A
- DTF $24.34
- Revenue Growth
- ASRT N/A
- DTF N/A
- 52 Week Low
- ASRT $0.73
- DTF $10.29
- 52 Week High
- ASRT $1.80
- DTF $11.19
- Technical
- Relative Strength Index (RSI)
- ASRT 45.42
- DTF 60.76
- Support Level
- ASRT $0.78
- DTF $11.16
- Resistance Level
- ASRT $0.85
- DTF $11.29
- Average True Range (ATR)
- ASRT 0.03
- DTF 0.06
- MACD
- ASRT 0.00
- DTF 0.01
- Stochastic Oscillator
- ASRT 56.14
- DTF 58.62
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
About DTF DTF Tax-Free Income 2028 Term Fund Inc.
DTF Tax-Free Income 2028 Term Fund Inc is a diversified closed-end management investment company. The Fund's investment objective is current income exempt from regular federal income tax consistent with the preservation of capital. It seeks to achieve its investment objective by investing primarily in a diversified portfolio of investment-grade tax-exempt obligations.